Responses
Endometrial cancer
2022-RA-1504-ESGO Tamoxifen-megestrol acetate combination hormonal therapy is an effective fertility-sparing treatment in early-stage endometrial cancer patients who have failed progestin only hormonal therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.